BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

April 30, 2024

https://www.globenewswire.com/news-release/2024/04/30/2872798/0/en/BioRestorative-Therapies-to-Report-First-Quarter-2024-Financial-Results-and-Host-Conference-Call-on-May-14-2024.html

– Company to provide update on exciting new commercial agreement, as well as Phase 2 clinical trial in Spine and preclinical development program in Obesity –

MELVILLE, N.Y., April 30, 2024 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced that it will release its first quarter 2024 financial results after market close on Tuesday, May 14, 2024.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.